Lexology November 28, 2022
Baker McKenzie

How will pharma use health data for clinical trials in the future? The power of clinical trial tokenisation

On 25 October 2022 leading researchers and executives from some of the world’s pioneering drug and pharmaceutical companies came together at a Financial Times Live Webinar event to discuss “The Power of Clinical Trial Tokenisation”.

Tokenisation of healthcare data is likely to be one of the next great innovations for developing life-saving drugs and treatments through the method of privacy preserving record linkage (PPRL). This allows pharmaceutical companies to ‘tokenise’ and link previously scattered patient datasets to produce unique insights. We’ve set out top 5 takeaways on tokenisation from the webinar below:

  1. How does it work? The digital token creates a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Trends
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
FDA Proposes the Establishment of the Center for Clinical Trial Innovation

Share This Article